Syntax Bio, Ajinomoto Partner to Evaluate Stem Cell Culture Tech
Syntax Bio and Ajinomoto Health & Nutrition North America Partner to Evaluate StemFit™ Media for Next-Generation Cell Therapy Workflows Syntax Bio, a synthetic biology company focused on programming the next…
Cataltheia and Bruno Vision Publish Landmark Study on Deseyne® Presbyopia Technology
Cataltheia Group Publishes Clinical Data Supporting Deseyne Contact Lens for Presbyopia in Optometry and Vision Science The Cataltheia Group and its U.S. subsidiary, Bruno Vision Care LLC, have announced the…
AdvanCell Launches U.S. Global Headquarters, Secures Flagship Boston Manufacturing Facility
AdvanCell Establishes U.S. Global Headquarters in Greater Boston, Expands Manufacturing Footprint to Support Radiopharmaceutical Growth AdvanCell, a clinical-stage radiopharmaceutical company focused on developing targeted alpha therapies for cancer, has announced…
Bioeconomy Sector Gets New Labour Market Intelligence Service
BioTalent Canada Launches BioInsights to Deliver Labour Market Intelligence for Canada’s Bio-Economy BioTalent Canada has unveiled BioInsights, a new labour market intelligence consulting service designed to support organizations operating across…
Syntax Bio Expands Series A Financing and Announces New Leadership Appointments
Syntax Bio Expands Series A to $14.4 Million, Strengthens Leadership Team and Advances Cell Programming Platform for Type 1 Diabetes Therapies Syntax Bio, a synthetic biology company focused on programming…
WISE Closes Oversubscribed €30 Million Series D Round, Adds ENEA Tech and Biomedical as Strategic Investor
WISE Raises €30 Million in Oversubscribed Series D Round to Advance Heron Spinal Cord Stimulation Lead and Expand Neurotechnology Platform WISE S.p.A., an Italian medical device company developing advanced implantable…
101 Therapeutics Unveils Clinical Evidence for 101-PGC-005 and Calls for Urgent Review in Bundibugyo Ebola Disease
101 Therapeutics Publicly Releases Clinical and Scientific Data for Macrophage-Targeted Anti-Inflammatory Candidate as It Seeks Urgent Review for Bundibugyo Ebola Outbreak Use 101 Therapeutics Ltd. has publicly released a broad…
Incyte Japan Wins Approval for Minjuvi Combo in Relapsed or Refractory DLBCL
Incyte Japan Secures Approval for Minjuvi Combo in Relapsed or Refractory DLBCL Incyte Biosciences Japan G.K. has secured a significant regulatory milestone in Japan with the approval of Minjuvi® (tafasitamab)…
Align Technology Announces Board Leadership Change as Raymond Larkin Retires and Kevin Conroy Becomes Chairman
Align Technology Names Kevin Conroy Board Chairman as Longtime Chair Ray Larkin Begins Leadership Transition Align Technology, Inc., the global medical device company best known for its Invisalign clear aligner…
Astrogen Wins 18th Folia Award for Autism Clinical Research Excellence
Astrogen Wins International Psychiatry Honor for Autism Clinical Trial Research, Strengthening Momentum for Speragen’s Global Development Astrogen, Inc., a South Korean biotechnology company focused on developing therapies for neurodevelopmental disorders,…
Imperative Care Analysis Highlights Early Thrombectomy Benefits in Intermediate-Risk PE
Imperative Care Reports New SYMPHONY-PE Analysis Highlighting Potential Benefits of Early Thrombectomy as Symphony Use Surpasses 500 U.S. Patients Imperative Care, a medical technology company focused on improving treatment options…
bioAffinity Technologies Closes $3.2 Million Offering
bioAffinity Technologies Closes $3.2 Million Public Offering to Support Growth in Lung Disease Diagnostics bioAffinity Technologies, Inc., a biotechnology company focused on developing noninvasive diagnostic tools for the early detection…